Trade Harvard Bioscience - HBIO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0244 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.9228 |
| Open | 1.9128 |
| 1-Year Change | -55.09% |
| Day's Range | 1.9028 - 1.9628 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 1.9328 | 0.0300 | 1.58% | 1.9028 | 1.9728 | 1.9028 |
| Jan 17, 2025 | 1.9128 | 0.0000 | 0.00% | 1.9128 | 1.9328 | 1.8728 |
| Jan 16, 2025 | 1.9028 | -0.0500 | -2.56% | 1.9528 | 1.9728 | 1.8828 |
| Jan 15, 2025 | 1.9628 | -0.0600 | -2.97% | 2.0228 | 2.0428 | 1.9128 |
| Jan 14, 2025 | 2.0028 | 0.0300 | 1.52% | 1.9728 | 2.0528 | 1.9228 |
| Jan 13, 2025 | 1.9628 | 0.0800 | 4.25% | 1.8828 | 1.9628 | 1.7928 |
| Jan 10, 2025 | 1.8828 | -0.2100 | -10.03% | 2.0928 | 2.0928 | 1.8628 |
| Jan 8, 2025 | 2.1228 | 0.0300 | 1.43% | 2.0928 | 2.1628 | 2.0628 |
| Jan 7, 2025 | 2.1328 | -0.0300 | -1.39% | 2.1628 | 2.2128 | 2.1028 |
| Jan 6, 2025 | 2.1628 | 0.0700 | 3.34% | 2.0928 | 2.2628 | 2.0728 |
| Jan 3, 2025 | 2.1228 | 0.0800 | 3.92% | 2.0428 | 2.1728 | 2.0428 |
| Jan 2, 2025 | 2.0128 | -0.0300 | -1.47% | 2.0428 | 2.1028 | 1.9728 |
| Dec 31, 2024 | 2.0828 | 0.0800 | 3.99% | 2.0028 | 2.0928 | 1.9828 |
| Dec 30, 2024 | 2.0028 | 0.0300 | 1.52% | 1.9728 | 2.0428 | 1.9428 |
| Dec 27, 2024 | 1.9728 | -0.1100 | -5.28% | 2.0828 | 2.0928 | 1.9328 |
| Dec 26, 2024 | 2.0828 | 0.0300 | 1.46% | 2.0528 | 2.1228 | 2.0328 |
| Dec 24, 2024 | 2.0628 | 0.0200 | 0.98% | 2.0428 | 2.0928 | 2.0028 |
| Dec 23, 2024 | 2.0828 | 0.0000 | 0.00% | 2.0828 | 2.1028 | 2.0328 |
| Dec 20, 2024 | 2.0928 | 0.0500 | 2.45% | 2.0428 | 2.1228 | 2.0428 |
| Dec 19, 2024 | 2.0828 | 0.0500 | 2.46% | 2.0328 | 2.1128 | 1.9928 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Harvard Bioscience Company profile
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. is a developer, manufacturer, and seller of technologies, products and services that enable fundamental research, discovery, and preclinical testing for drug development. The Company provides products that support research in six different classes of laboratory use, including molecular, cellular, tissue, organ, organisms, and clinical. The Company primarily sells its products under several brand names, including Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The Company’s customers include pharmaceutical and biotechnology companies, as well as contract research organizations, academic labs, and government researchers.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Harvard Bioscience, Inc. revenues increased 16% to $118.9M. Net loss decreased 96% to $288K. Revenues reflect United States segment increase of 18% to $49.8M, Europe segment increase of 19% to $35.8M. Lower net loss reflects Interest expense decrease of 68% to $1.5M (expense), G/L on early Exting of lease relat debt decrease from $1.9M (expense) to $0K.
Equity composition
Common Stock $.01 Par, 12/10, 80M auth., 36,057,974 issd., less 7,745,507 shs. in Treas. @ 10.7M. Insiders & Strategic holders own 13.56%. IPO: 12/7/2000, 6,420,000 shs. @$8 by Thomas Weisel Partners LLC. *NOTE: 10/02, Company acquired Genomic Solutions, Inc. @ 0.1017 shares and $0.286 in cash (3,178,857 shares issd.).
| Industry: | Advanced Medical Equipment & Technology (NEC) |
84 October Hill Rd
HOLLISTON
MASSACHUSETTS 01746-1371
US
News
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
15:24, 21 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com